S
Skye Peptides
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Mazdutide | A | 5 | 7.7 | 7.1 | 8.2 | 6 May 2025 |
| Semaglutide | A | 9 | 8.2 | 7.2 | 8.6 | 17 Dec 2024 |
| Tirzepatide | A | 11 | 7.9 | 6.2 | 8.8 | 17 Dec 2024 |
| Retatrutide | B | 10 | 7.9 | 6.0 | 9.5 | 17 Dec 2024 |
| Ipamorelin | B | 5 | 6.4 | 5.4 | 7.7 | 27 Feb 2025 |
| Melanotan II | B | 4 | 6.3 | 5.1 | 7.5 | 27 Feb 2025 |
| Survodutide | B | 4 | 6.8 | 6.1 | 7.3 | 6 May 2025 |
| Tesamorelin | B | 5 | 6.1 | 5.0 | 7.1 | 14 May 2025 |
| CJC-1295 | C | 7 | 6.9 | 4.3 | 8.2 | 17 Dec 2024 |
| BPC-157 | E | 12 | 6.1 | 2.6 | 8.5 | 17 Dec 2024 |
| Abaloparatide | A | 7 | 7.2 | 5.6 | 10.0 | 25 May 2026 |
| ACE-031 | A | 2 | 7.2 | 6.1 | 8.4 | 21 May 2026 |
| Andarine S4 | A | 2 | 7.1 | 5.6 | 8.7 | 23 May 2026 |
| ARA-290 | A | 6 | 8.0 | 5.3 | 10.0 | 20 May 2026 |
| Arimidex (Anastrozole) | A | 2 | 7.5 | 6.3 | 8.7 | 23 May 2026 |
| Boldenone Cypionate | A | 6 | 6.6 | 5.3 | 9.8 | 21 May 2026 |
| BPC157 10mg + TB500 10mg Blend | A | 5 | 5.8 | 3.5 | 7.7 | 24 May 2026 |
| Cerebrolysin | A | 7 | 6.7 | 5.0 | 9.2 | 23 May 2026 |
| CJC-1295 With DAC | A | 7 | 7.3 | 6.3 | 9.2 | 24 May 2026 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | A | 6 | 7.2 | 4.9 | 8.1 | 26 Jan 2026 |
| DHB (1-Test Cyp) Oral | A | 6 | 6.8 | 4.8 | 8.4 | 24 May 2026 |
| EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 | X | 1 | 5.7 | 5.7 | 5.7 | 8 Jul 2025 |
| FOXO4 | A | 6 | 8.0 | 6.8 | 8.9 | 21 May 2026 |
| GHRP-2 Acetate | X | 1 | 8.1 | 8.1 | 8.1 | 7 May 2025 |
| IGF-1 LR3 | A | 6 | 7.3 | 4.6 | 9.1 | 23 May 2026 |
| KissPeptin-10 | A | 6 | 6.4 | 4.5 | 8.2 | 21 May 2026 |
| Liraglutide | A | 4 | 8.1 | 6.9 | 8.9 | 26 Jan 2026 |
| Livagen | A | 5 | 7.6 | 6.2 | 8.6 | 24 May 2026 |
| Methylamine (base) CAS 74-89-5 | A | 2 | 7.2 | 6.6 | 7.8 | 23 May 2026 |
| MOTS-C | A | 3 | 7.7 | 6.2 | 10.0 | 21 May 2026 |
| Nandrolone Phenylpropionate (NPP) Raw | A | 3 | 8.3 | 6.8 | 9.6 | 24 May 2026 |
| Ovagen | A | 6 | 6.6 | 3.1 | 8.1 | 25 May 2026 |
| Oxymetholone (Anadrol) Raw | A | 6 | 8.2 | 6.8 | 9.4 | 19 Jan 2026 |
| PE 22-28 | A | 5 | 7.4 | 5.1 | 8.7 | 21 May 2026 |
| Primobolan Oral (Methenolone Acetate) | A | 4 | 7.5 | 6.5 | 9.5 | 24 May 2026 |
| Retatrutide 30mg Pen Kit | A | 2 | 7.8 | 5.9 | 9.7 | 24 May 2026 |
| S-23 Raw | A | 5 | 7.6 | 6.7 | 8.7 | 24 May 2026 |
| Selank | A | 5 | 6.8 | 4.0 | 8.7 | 19 Jan 2026 |
| T3 (Liothyronine) | X | 1 | 6.9 | 6.9 | 6.9 | 14 Jan 2025 |
| Test Base (No Ester) | A | 3 | 7.9 | 6.9 | 8.7 | 24 May 2026 |
| Tren Hex | A | 7 | 7.2 | 5.3 | 9.4 | 21 May 2026 |
| TrenMix 200 | A | 6 | 8.0 | 5.7 | 9.7 | 23 May 2026 |
| Trestolone Enanthate Raw | A | 7 | 7.5 | 6.1 | 9.8 | 25 May 2026 |
| YK11 | A | 4 | 6.8 | 5.0 | 9.3 | 23 May 2026 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | ARA-290 | 8.6 | 5mg | 5.3mg | +6.0% | 97.95% | Lab G |
| 25 May 2026 | S-23 Raw | 6.9 | 5g | 5.9g | +18.9% | 98.89% | Lab A |
| 24 May 2026 | Boldenone Cypionate | 6.2 | 200mg/ml | 209.1mg/ml | +4.6% | 96.80% | Lab A |
| 24 May 2026 | Cerebrolysin | 5.9 | 2mg | 2.1mg | +7.5% | 99.60% | Lab D |
| 24 May 2026 | IGF-1 LR3 | 6.3 | 5mg | 5.9mg | +17.5% | 96.61% | Lab D |
| 24 May 2026 | Livagen | 9.1 | 15mg | 15.6mg | +4.2% | 99.92% | Lab E |
| 24 May 2026 | Nandrolone Phenylpropionate (NPP) Raw | 7.3 | 5g | 4.9g | -2.5% | 95.45% | Lab E |
| 24 May 2026 | Ovagen | 8.8 | 20mg | 21.3mg | +6.5% | 95.31% | Lab F |
| 24 May 2026 | Retatrutide 30mg Pen Kit | 8.0 | 20mg | 18.0mg | -10.2% | 96.56% | Lab E |
| 24 May 2026 | Tren Hex | 6.9 | 200mg/ml | 185.5mg/ml | -7.3% | 99.30% | Lab G |
| 24 May 2026 | YK11 | 7.7 | 20mg | 22.6mg | +12.8% | 97.87% | Lab G |
| 24 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 7.2 | 30mg | 33.0mg | +9.9% | 99.48% | Lab G |
| 24 May 2026 | EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 | 6.9 | 100g | 123.5g | +23.5% | 99.65% | Lab F |
| 24 May 2026 | Retatrutide 30mg Pen Kit | 9.1 | 15mg | 17.2mg | +14.4% | 96.27% | Lab B |
| 24 May 2026 | Andarine S4 | 6.6 | 25mg | 23.4mg | -6.3% | 96.53% | Lab C |
| 24 May 2026 | Boldenone Cypionate | 5.3 | 250mg/ml | 281.6mg/ml | +12.6% | 96.21% | Lab F |
| 24 May 2026 | Nandrolone Phenylpropionate (NPP) Raw | 8.1 | 5g | 4.4g | -12.6% | 97.24% | Lab G |
| 24 May 2026 | Ovagen | 7.2 | 10mg | 12.0mg | +19.7% | 98.94% | Lab C |
| 24 May 2026 | Oxymetholone (Anadrol) Raw | 6.9 | 500g | 431.5g | -13.7% | 97.81% | Lab C |
| 24 May 2026 | Abaloparatide | 6.8 | 15mg | 18.5mg | +23.2% | 95.73% | Lab E |
| 24 May 2026 | Cerebrolysin | 6.3 | 50mg | 54.2mg | +8.3% | 95.62% | Lab B |
| 24 May 2026 | Liraglutide | 8.9 | 50mg | 53.7mg | +7.4% | 98.44% | Lab B |
| 24 May 2026 | MOTS-C | 6.6 | 2mg | 1.8mg | -9.3% | 98.81% | Lab A |
| 24 May 2026 | MOTS-C | 9.2 | 2mg | 2.2mg | +7.8% | 96.24% | Lab E |
| 24 May 2026 | Test Base (No Ester) | 8.4 | 100mg/ml | 111.7mg/ml | +11.7% | 95.18% | Lab F |
| 24 May 2026 | TrenMix 200 | 6.4 | 100mg/ml | 113.2mg/ml | +13.2% | 97.33% | Lab C |
| 24 May 2026 | Cerebrolysin | 6.6 | 20mg | 20.9mg | +4.7% | 97.34% | Lab E |
| 24 May 2026 | CJC-1295 With DAC | 7.0 | 10mg | 10.2mg | +1.5% | 96.89% | Lab E |
| 24 May 2026 | GHRP-2 Acetate | 5.6 | 20mg | 23.7mg | +18.7% | 95.37% | Lab B |
| 24 May 2026 | Liraglutide | 8.3 | 10mg | 9.2mg | -7.9% | 99.25% | Lab C |
| 24 May 2026 | Trestolone Enanthate Raw | 9.3 | 500g | 471.5g | -5.7% | 98.45% | Lab B |
| 23 May 2026 | MOTS-C | 7.8 | 20mg | 24.6mg | +22.9% | 95.11% | Lab G |
| 23 May 2026 | Oxymetholone (Anadrol) Raw | 7.6 | 10g | 10.3g | +2.5% | 96.11% | Lab F |
| 23 May 2026 | S-23 Raw | 7.0 | 1g | 1.1g | +9.0% | 95.79% | Lab G |
| 23 May 2026 | S-23 Raw | 7.8 | 5g | 5.2g | +3.6% | 95.00% | Lab F |
| 23 May 2026 | Trestolone Enanthate Raw | 8.3 | 5g | 6.1g | +21.5% | 95.48% | Lab D |
| 23 May 2026 | CJC-1295 With DAC | 6.8 | 2mg | 2.0mg | -0.9% | 99.87% | Lab E |
| 23 May 2026 | Selank | 5.9 | 20mg | 24.6mg | +23.2% | 99.17% | Lab B |
| 23 May 2026 | TrenMix 200 | 7.0 | 250mg/ml | 306.8mg/ml | +22.7% | 99.40% | Lab G |
| 22 May 2026 | BPC-157 | 7.7 | 5mg | 6.0mgpackage | 5.33mg | -11.0% | BPC25-05-002 |
| 21 May 2026 | ACE-031 | 6.9 | 10mg | 12.3mg | +23.3% | 98.85% | Lab G |
| 21 May 2026 | Arimidex (Anastrozole) | 8.1 | 20mg | 18.4mg | -8.0% | 97.77% | Lab B |
| 21 May 2026 | KissPeptin-10 | 5.8 | 20mg | 18.8mg | -6.1% | 98.79% | Lab G |
| 21 May 2026 | Oxymetholone (Anadrol) Raw | 7.6 | 500g | 497.2g | -0.6% | 97.84% | Lab E |
| 21 May 2026 | Tren Hex | 7.6 | 100mg/ml | 123.2mg/ml | +23.2% | 96.78% | Lab F |
| 21 May 2026 | TrenMix 200 | 9.9 | 250mg/ml | 238.9mg/ml | -4.4% | 97.70% | Lab G |
| 21 May 2026 | Trestolone Enanthate Raw | 6.8 | 500g | 562.5g | +12.5% | 96.54% | Lab A |
| 21 May 2026 | Tirzepatide | 8.0 | 30mg | (no batch claim) | 30.7mg | +2.3% | (no batch ID) |
| 21 May 2026 | Liraglutide | 8.3 | 5mg | 6.1mg | +21.5% | 96.47% | Lab C |
| 21 May 2026 | Methylamine (base) CAS 74-89-5 | 7.4 | 1g | 1.0g | +3.4% | 96.91% | Lab E |
| 21 May 2026 | Ovagen | 6.8 | 2mg | 1.7mg | -13.7% | 95.26% | Lab G |
| 21 May 2026 | PE 22-28 | 5.3 | 2mg | 2.2mg | +7.8% | 98.04% | Lab A |
| 21 May 2026 | TrenMix 200 | 8.7 | 250mg/ml | 271.0mg/ml | +8.4% | 97.52% | Lab G |
| 20 May 2026 | ARA-290 | 6.7 | 50mg | 52.3mg | +4.6% | 99.85% | Lab A |
| 20 May 2026 | Arimidex (Anastrozole) | 7.1 | 50mg | 56.9mg | +13.9% | 98.60% | Lab C |
| 20 May 2026 | Boldenone Cypionate | 9.5 | 250mg/ml | 256.6mg/ml | +2.6% | 98.86% | Lab E |
| 20 May 2026 | BPC157 10mg + TB500 10mg Blend | 4.3 | 20mg | 20.4mg | +2.0% | 95.55% | Lab G |
| 20 May 2026 | IGF-1 LR3 | 6.3 | 20mg | 19.4mg | -3.0% | 96.28% | Lab C |
| 20 May 2026 | Liraglutide | 10.0 | 30mg | 35.0mg | +16.7% | 96.88% | Lab F |
| 20 May 2026 | Ovagen | 7.8 | 5mg | 5.8mg | +15.1% | 97.10% | Lab E |
| 20 May 2026 | Primobolan Oral (Methenolone Acetate) | 6.7 | 50mg | 56.3mg | +12.6% | 96.93% | Lab F |
| 19 May 2026 | Abaloparatide | 8.3 | 30mg | 33.4mg | +11.4% | 97.35% | Lab F |
| 19 May 2026 | ACE-031 | 7.2 | 20mg | 23.1mg | +15.3% | 98.46% | Lab A |
| 19 May 2026 | CJC-1295 With DAC | 6.2 | 15mg | 13.7mg | -8.7% | 96.63% | Lab A |
| 19 May 2026 | FOXO4 | 7.9 | 15mg | 13.8mg | -8.2% | 96.81% | Lab C |
| 19 May 2026 | PE 22-28 | 7.5 | 15mg | 16.9mg | +12.9% | 98.61% | Lab A |
| 19 May 2026 | Selank | 8.1 | 5mg | 5.6mg | +12.4% | 99.23% | Lab F |
| 19 May 2026 | Tren Hex | 5.5 | 250mg/ml | 272.4mg/ml | +9.0% | 95.41% | Lab E |
| 17 May 2026 | Tesamorelin | 5.0 | 10mg | (no batch claim) | 11.6mg | +16.0% | (no batch ID) |
| 17 May 2026 | Ipamorelin | 7.7 | 10mg | 11.6mgpackage | 10.4mg | -10.2% | IPA-10-001 |
| 17 May 2026 | ARA-290 | 7.4 | 30mg | 29.3mg | -2.5% | 98.58% | Lab F |
| 17 May 2026 | Boldenone Cypionate | 5.8 | 250mg/ml | 229.5mg/ml | -8.2% | 95.64% | Lab F |
| 17 May 2026 | DHB (1-Test Cyp) Oral | 5.1 | 20mg | 23.1mg | +15.5% | 95.82% | Lab F |
| 17 May 2026 | DHB (1-Test Cyp) Oral | 7.2 | 10mg | 11.8mg | +17.8% | 98.09% | Lab D |
| 17 May 2026 | FOXO4 | 10.0 | 20mg | 17.4mg | -13.2% | 97.37% | Lab G |
| 17 May 2026 | S-23 Raw | 6.2 | 5g | 4.3g | -13.3% | 96.03% | Lab A |
| 17 May 2026 | YK11 | 4.8 | 25mg | 29.8mg | +19.1% | 99.42% | Lab B |
| 29 Jan 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 7.3 | 20mg | 21.1mg | +5.6% | 99.86% | Lab D |
| 29 Jan 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 7.6 | 2mg | 2.2mg | +8.4% | 97.21% | Lab D |
| 29 Jan 2026 | IGF-1 LR3 | 7.4 | 20mg | 21.2mg | +6.0% | 98.66% | Lab A |
| 29 Jan 2026 | Livagen | 6.1 | 20mg | 20.9mg | +4.5% | 97.67% | Lab G |
| 29 Jan 2026 | PE 22-28 | 8.0 | 2mg | 2.1mg | +4.4% | 96.31% | Lab D |
| 26 Jan 2026 | Tirzepatide | 7.2 | 60mg | (no batch claim) | 64.5mg | +7.5% | (no batch ID) |
| 26 Jan 2026 | Abaloparatide | 6.5 | 15mg | 13.7mg | -8.7% | 95.45% | Lab F |
| 26 Jan 2026 | Boldenone Cypionate | 6.1 | 250mg/ml | 288.9mg/ml | +15.5% | 95.37% | Lab E |
| 26 Jan 2026 | TrenMix 200 | 7.6 | 200mg/ml | 219.0mg/ml | +9.5% | 98.94% | Lab C |
| 19 Jan 2026 | DHB (1-Test Cyp) Oral | 8.6 | 100mg | 103.8mg | +3.8% | 98.45% | Lab A |
| 19 Jan 2026 | Tren Hex | 7.7 | 100mg/ml | 97.8mg/ml | -2.2% | 97.09% | Lab D |
| 9 Jan 2026 | Tesamorelin | 5.6 | 10mg | 10.7mglabel | 9.38mg | -12.1% | TESA25-10-004 |
| 9 Jan 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 4.1 | 15mg | 13.5mg | -9.8% | 96.83% | Lab F |
| 9 Jan 2026 | Primobolan Oral (Methenolone Acetate) | 9.6 | 50mg | 57.0mg | +14.1% | 97.24% | Lab D |
| 9 Jan 2026 | Tren Hex | 6.5 | 250mg/ml | 270.7mg/ml | +8.3% | 95.25% | Lab B |
| 9 Jan 2026 | YK11 | 7.9 | 10mg | 9.8mg | -1.6% | 98.76% | Lab C |
| 7 Jan 2026 | BPC157 10mg + TB500 10mg Blend | 4.8 | 15mg | 16.2mg | +8.1% | 99.73% | Lab G |
| 7 Jan 2026 | KissPeptin-10 | 6.7 | 5mg | 5.6mg | +12.0% | 96.58% | Lab C |
| 7 Jan 2026 | KissPeptin-10 | 6.0 | 5mg | 5.9mg | +18.7% | 97.89% | Lab D |
| 7 Jan 2026 | S-23 Raw | 10.0 | 100g | 122.5g | +22.5% | 97.04% | Lab A |
| 6 Jan 2026 | Abaloparatide | 6.5 | 50mg | 50.9mg | +1.8% | 96.69% | Lab E |
| 6 Jan 2026 | IGF-1 LR3 | 7.6 | 10mg | 11.4mg | +13.6% | 95.44% | Lab D |
| 29 Dec 2025 | Cerebrolysin | 6.2 | 5mg | 6.0mg | +19.1% | 95.49% | Lab F |
| 29 Dec 2025 | FOXO4 | 7.5 | 30mg | 32.1mg | +7.0% | 99.94% | Lab F |
| 29 Dec 2025 | FOXO4 | 9.6 | 50mg | 44.0mg | -11.9% | 97.45% | Lab F |
| 29 Dec 2025 | Methylamine (base) CAS 74-89-5 | 6.1 | 10g | 10.6g | +5.8% | 95.57% | Lab C |
| 29 Dec 2025 | Oxymetholone (Anadrol) Raw | 7.0 | 1g | 1.1g | +7.7% | 97.18% | Lab A |
| 16 Dec 2025 | BPC-157 | 6.9 | 10mg | 11.4mglabel | 10.6mg | -6.7% | BPC25-10-001 |
| 12 Dec 2025 | Abaloparatide | 5.4 | 50mg | 60.5mg | +20.9% | 96.31% | Lab G |
| 12 Dec 2025 | BPC157 10mg + TB500 10mg Blend | 5.2 | 15mg | 14.0mg | -6.5% | 95.77% | Lab G |
| 12 Dec 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 8.4 | 50mg | 43.9mg | -12.2% | 97.22% | Lab G |
| 12 Dec 2025 | DHB (1-Test Cyp) Oral | 5.6 | 20mg | 23.8mg | +19.2% | 95.76% | Lab C |
| 5 Dec 2025 | Primobolan Oral (Methenolone Acetate) | 8.1 | 20mg | 21.2mg | +5.9% | 99.66% | Lab C |
| 5 Dec 2025 | Test Base (No Ester) | 9.3 | 250mg/ml | 239.9mg/ml | -4.0% | 99.81% | Lab A |
| 5 Dec 2025 | Tren Hex | 8.3 | 100mg/ml | 106.4mg/ml | +6.4% | 96.44% | Lab D |
| 5 Dec 2025 | Trestolone Enanthate Raw | 9.3 | 10g | 10.3g | +3.2% | 98.97% | Lab B |
| 23 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 7.0 | 20mg | 23.0mg | +14.8% | 96.94% | Lab C |
| 23 Nov 2025 | CJC-1295 With DAC | 8.6 | 10mg | 9.2mg | -7.9% | 99.86% | Lab A |
| 23 Nov 2025 | IGF-1 LR3 | 9.6 | 15mg | 14.1mg | -5.9% | 95.10% | Lab F |
| 23 Nov 2025 | Test Base (No Ester) | 10.0 | 200mg/ml | 213.6mg/ml | +6.8% | 98.70% | Lab B |
| 23 Nov 2025 | Trestolone Enanthate Raw | 8.3 | 5g | 5.8g | +15.5% | 96.71% | Lab B |
| 17 Nov 2025 | FOXO4 | 8.9 | 10mg | 12.5mg | +24.7% | 99.32% | Lab A |
| 17 Nov 2025 | KissPeptin-10 | 5.4 | 5mg | 5.9mg | +17.9% | 97.26% | Lab E |
| 17 Nov 2025 | Oxymetholone (Anadrol) Raw | 8.0 | 5g | 4.5g | -9.8% | 96.73% | Lab D |
| 14 Nov 2025 | ARA-290 | 9.0 | 5mg | 4.3mg | -13.2% | 95.50% | Lab B |
| 14 Nov 2025 | Boldenone Cypionate | 6.7 | 250mg/ml | 235.7mg/ml | -5.7% | 95.57% | Lab F |
| 14 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 7.9 | 20mg | 23.0mg | +14.9% | 98.04% | Lab F |
| 5 Nov 2025 | Abaloparatide | 8.9 | 30mg | 36.6mg | +22.0% | 99.20% | Lab C |
| 5 Nov 2025 | CJC-1295 With DAC | 6.6 | 15mg | 17.9mg | +19.1% | 96.17% | Lab B |
| 5 Nov 2025 | DHB (1-Test Cyp) Oral | 7.7 | 100mg | 124.7mg | +24.7% | 98.46% | Lab D |
| 5 Nov 2025 | Livagen | 5.5 | 15mg | 15.7mg | +5.0% | 95.48% | Lab G |
| 5 Nov 2025 | Livagen | 8.0 | 5mg | 5.4mg | +8.1% | 98.90% | Lab B |
| 5 Nov 2025 | PE 22-28 | 5.2 | 30mg | 26.7mg | -11.1% | 97.44% | Lab C |
| 5 Nov 2025 | Selank | 6.8 | 10mg | 10.2mg | +1.8% | 99.22% | Lab G |
| 5 Nov 2025 | Tren Hex | 7.9 | 300mg/ml | 290.9mg/ml | -3.0% | 95.18% | Lab F |
| 5 Nov 2025 | Trestolone Enanthate Raw | 6.7 | 5g | 5.6g | +12.7% | 99.25% | Lab G |
| 4 Nov 2025 | Cerebrolysin | 5.7 | 20mg | 20.0mg | -0.2% | 99.15% | Lab A |
| 4 Nov 2025 | CJC-1295 With DAC | 7.9 | 10mg | 9.1mg | -9.1% | 96.43% | Lab A |
| 4 Nov 2025 | FOXO4 | 5.7 | 5mg | 6.0mg | +20.8% | 99.81% | Lab B |
| 4 Nov 2025 | Livagen | 7.0 | 10mg | 10.5mg | +4.5% | 96.65% | Lab F |
| 4 Nov 2025 | Nandrolone Phenylpropionate (NPP) Raw | 8.9 | 100g | 109.9g | +9.9% | 99.76% | Lab F |
| 4 Nov 2025 | Ovagen | 7.5 | 15mg | 13.1mg | -12.6% | 97.55% | Lab B |
| 4 Nov 2025 | Oxymetholone (Anadrol) Raw | 8.3 | 10g | 8.8g | -12.4% | 95.53% | Lab G |
| 4 Nov 2025 | Primobolan Oral (Methenolone Acetate) | 9.9 | 100mg | 93.2mg | -6.8% | 96.34% | Lab F |
| 4 Nov 2025 | Selank | 7.3 | 15mg | 14.1mg | -6.3% | 95.96% | Lab G |
| 4 Nov 2025 | TrenMix 200 | 6.8 | 300mg/ml | 268.3mg/ml | -10.6% | 98.51% | Lab D |
| 17 Oct 2025 | ARA-290 | 6.8 | 20mg | 17.9mg | -10.5% | 99.29% | Lab F |
| 17 Oct 2025 | Cerebrolysin | 6.6 | 50mg | 49.5mg | -1.1% | 99.16% | Lab G |
| 17 Oct 2025 | IGF-1 LR3 | 8.8 | 5mg | 5.8mg | +16.6% | 99.70% | Lab E |
| 17 Oct 2025 | KissPeptin-10 | 7.1 | 2mg | 2.4mg | +21.2% | 98.57% | Lab C |
| 17 Oct 2025 | Ovagen | 8.8 | 30mg | 33.0mg | +10.1% | 96.34% | Lab B |
| 17 Oct 2025 | Selank | 7.4 | 30mg | 34.1mg | +13.8% | 98.96% | Lab B |
| 17 Oct 2025 | Trestolone Enanthate Raw | 8.2 | 1g | 1.2g | +16.7% | 97.92% | Lab E |
| 17 Oct 2025 | YK11 | 5.3 | 20mg | 22.3mg | +11.7% | 98.83% | Lab A |
| 9 Oct 2025 | ARA-290 | 7.9 | 5mg | 5.0mg | +0.5% | 98.41% | Lab C |
| 9 Oct 2025 | Cerebrolysin | 5.8 | 15mg | 14.1mg | -6.1% | 97.96% | Lab G |
| 9 Oct 2025 | CJC-1295 With DAC | 8.3 | 10mg | 10.7mg | +7.4% | 98.68% | Lab C |
| 9 Oct 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 8.2 | 20mg | 23.9mg | +19.7% | 98.16% | Lab B |
| 9 Oct 2025 | PE 22-28 | 8.2 | 10mg | 11.4mg | +14.3% | 96.93% | Lab F |
| 9 Oct 2025 | T3 (Liothyronine) | 9.0 | 25mg | 23.7mg | -5.3% | 96.96% | Lab D |
| 3 Oct 2025 | Abaloparatide | 7.7 | 50mg | 61.9mg | +23.9% | 96.40% | Lab B |
| 3 Oct 2025 | Andarine S4 | 7.3 | 50mg | 46.1mg | -7.8% | 95.34% | Lab G |
| 3 Oct 2025 | DHB (1-Test Cyp) Oral | 6.2 | 10mg | 12.2mg | +22.1% | 97.58% | Lab G |
| 3 Oct 2025 | KissPeptin-10 | 7.5 | 15mg | 14.8mg | -1.4% | 99.25% | Lab B |